Merus N.V.·4

Jan 31, 4:30 PM ET

Zohren Fabian 4

4 · Merus N.V. · Filed Jan 31, 2025

Insider Transaction Report

Form 4
Period: 2025-01-29
Zohren Fabian
Chief Medical Officer
Transactions
  • Award

    Share Option (right to buy)

    2025-01-29+50,00050,000 total
    Exercise: $41.65Exp: 2035-01-29Common Shares (50,000 underlying)
Footnotes (1)
  • [F1]Options vest over a four-year period from January 1, 2025. 25% vest on January 1, 2026 and in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4